WHO recommended not to use remdesivir on extreme covid-19 cases last week. According to first scientific study, Mumbai doctors have recommended to use favipivir on patients with mild covid-19 symptoms. They have also said that favipivir reduces the “cure time”.
“We found favipiravir improved the time to clinical cure by around three days,” said the study’s main author Dr Zarir F Udwadia.
Patients dosed with this vaccine have cleared 30% of the virus (two days) in comparison to the standard treatment.
“This may not sound like a very big difference, but is significant. There are so few treatment options that when a drug gives even a promising signal, it’s exciting news,” said Dr Udwadia.
Since the pandemic began almost a year back in Wuhan, China, various drugs have been tried out to control it. However, apart from steroids, none of the other drugs ranging from plasma to remdesivir to HCQS have been scientifically shown to help Covid-19 patients.